The stabilized MALT1 activates CARMA3–Bcl10–MALT1 pathway in angiotensin II receptor-positive breast cancer, leading to the promotion of cancer cell proliferation and invasion [73, 74]. This evidence concerns the gene MALT1 and breast carcinoma.